Back

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome

European Heart Journal

15 November 2022
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes

Contributors

Jean-Claude Tardif
Jean-Claude Tardif

Author

Montreal Heart Institute Montreal , Canada

Marc A Pfeffer
Marc A Pfeffer

Author

Marie-Pierre Dubé
Marie-Pierre Dubé

Author

Author

You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
13 October 2025
thumbnail
Congress Presentation
The optimization of dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction in dependence on the vasculoendothelial growth factor-A gene polymorphism G634C (rs2010963)
29 June 2021
thumbnail
Congress Presentation
Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
27 August 2022
thumbnail
Congress Presentation
Pharmacogenetics for mavacamten treatment individualization in patients with obstructive hypertrophic cardiomyopathy
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources